Author

E. Becht

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 3 Research Focus:cell type annotation· 3 Organism:human· 3 Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:clustering· 1 Assay:flow cytometry· 1

Frequent Co-Authors

A. de Reynies· 2 shared E. W. Newell· 2 shared A. Mezheyeuski· 1 shared A. Miranda· 1 shared A. TAKANO· 1 shared A. W. Zhang· 1 shared B. H. Nelson· 1 shared C. Sautes-Fridman· 1 shared

Activity by Year

2018-2020 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 15 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

A. de Reynies

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

webMCP-counter: a web interface for transcriptomics-based quantification of immune and stromal cells in heterogeneous human or murine samples

M. Meylan, E. Becht, C. Sautes-Fridman, A. de Reynies, W. H. Fridman, F. Petitprez

webMCP-counter provides a web interface for using MCP-counter and mMCP-counter methods to estimate immune and stromal cell composition in bulk transcriptomic data from human or murine samples.

bioRxiv · Dec 3, 2020 · PreprintImmunology

Infinity Flow: High-throughput single-cell quantification of 100s of proteins using conventional flow cytometry and machine learning

E. Becht, D. Tolstrup, C.-A. Dutertre, F. Ginhoux, E. W. Newell, R. Gottardo, M. B. Headley

Infinity Flow uses flow cytometry and machine learning to analyze hundreds of proteins across millions of cells, revealing novel lung cellular heterogeneity in melanoma metastasis models.

bioRxiv · Jun 17, 2020Immunology

Partial absence of PD-1 expression by tumor-specific CD8+ T cells in EBV-driven lymphoepithelioma-like carcinoma: a case report

Y. SIMONI, E. Becht, S. Li, C. Y. LOH, J. P. S. YEONG, T. K. H. LIM, A. TAKANO, D. S. W. TAN, E. W. NEWELL

This study reports the absence of PD-1 expression on EBV-specific CD8+ T cells in LELC, suggesting anti-PD1/PD-L1 therapy may not be effective for this cancer type.

bioRxiv · Jul 9, 2019 · PreprintCancer Biology

Cancer stemness, intratumoral heterogeneity, and immune response across cancers

A. Miranda, P. T. Hamilton, A. W. Zhang, E. Becht, A. Mezheyeuski, J. Bruun, P. Micke, A. De Reynies, B. H. Nelson

The paper assesses the relationship between cancer stemness and immune response across 21 solid cancers, finding negative associations between stemness and anticancer immunity.

bioRxiv · Jun 20, 2018Cancer Biology